Shareholder Value and Financial Outlook
2022 FULL YEAR RESULTS
EPS
Adjusted EPS*
REVENUE AND
MEDICAL CUSTOMERS
$23.27
Total revenues
KEY RATIOS
$180.5B
Medical care ratio
81.7%
Total medical customers
18M
Adjusted SG&A expense ratio*
7.2%
ADJUSTED INCOME
FROM OPERATIONS
Medical customer YTD
growth
923K
Debt-to-capitalization ratio
40.9%
Enterprise, after tax*
$7.3B
CAPITAL DEPLOYMENT
Evernorth, pre-tax
$6.1B
Cash flow from
$8.7B
operations
Cigna Healthcare, pre-tax
$4.1B
Weighted average
shares outstanding
YTD share repurchase
through Dec. 31, 2022
313.1M
27.4M shares
for $7.6B
*See the Appendix for a reconciliation of adjusted EPS, consolidated adjusted income from operations and adjusted SG&A expense ratio to diluted EPS,
shareholders' net income and SG&A expense ratio.
Confidential unpublishedproperty of Cigra.2023 CignaView entire presentation